RYHTY (Ryman Healthcare) Revenue: $425.8 Mil (TTM As of Mar. 2025)


RYHTY Ryman Healthcare Ltd RYHTY
70 GF Score
Price $6.11
View Full Analysis

What is Ryman Healthcare Revenue?

Ryman Healthcare RYHTY -12.82% 70 Revenue is $425.8 Mil as of Mar. 2025. GuruFocus rates RYHTY with a GF Score™ of 70/100.

Ryman Healthcare's revenue for the six months ended in Mar. 2025 was $212.5 Mil. Its revenue for the trailing twelve months (TTM) ended in Mar. 2025 was $425.8 Mil. Ryman Healthcare's Revenue per Share for the six months ended in Mar. 2025 was $1.54. Its Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2025 was $2.99.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get other companies' revenue growth rate using Revenue per Share data.


Ryman Healthcare  (OTCPK:RYHTY) Revenue Explanation

In ranking the predictability, companies with more consistent revenue and earnings growth are ranked high with predictability.

Peter Lynch categorized companies according to their revenue growth:


Slow Grower: Inflation < 10-Year Revenue Growth Rate < 10%:
Stalwart: 10% < 10-Year Revenue Growth Rate < 20%:
Fast Grower: 10-Year Revenue Growth Rate > 20%:

His favorite companies are stalwart, those growing between 10-20% a year.

Companies in cyclical industries may see their revenue fluctuate wildly in good years and bad years.


Be Aware

Revenue can be manipulated by changing the way how revenue is booked. Companies may book sales before the payment is received, or before the revenue is fully earned. These will be added to balance sheet items such as account payable or account receivables.


Ryman Healthcare Revenue Related Terms


Ryman Healthcare Revenue Historical Data

* Premium members only.

The historical data trend for Ryman Healthcare's Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Ryman Healthcare Revenue Chart

Ryman Healthcare Annual Data
Trend Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25
Revenue
Get a 7-Day Free Trial Premium Member Only Premium Member Only 322.92 345.99 347.68 395.70 408.82

Ryman Healthcare Semi-Annual Data
Sep15 Mar16 Sep16 Mar17 Sep17 Mar18 Sep18 Mar19 Sep19 Mar20 Sep20 Mar21 Sep21 Mar22 Sep22 Mar23 Sep23 Mar24 Sep24 Mar25
Revenue Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 180.12 187.82 203.08 213.33 212.48

RYHTY vs HCA, THC, DVA: Revenue Comparison

For the Medical Care Facilities subindustry, Ryman Healthcare's Revenue, along with its competitors' market caps and Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Ryman Healthcare Revenue vs Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Ryman Healthcare's Revenue distribution charts can be found below:

* The bar in red indicates where Ryman Healthcare's Revenue falls into.


RYHTY
70GF Score
Ryman Healthcare Ltd RYHTY
Revenue is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Ryman Healthcare Revenue Calculation

Also referred as sales, revenue is income that a company receives from its normal business activities, usually from the sale of goods and services to customers. Revenue is often referred to as the "top line" due to its position on the income statement at the very top.

Revenue for the trailing twelve months (TTM) ended in Mar. 2025 adds up the semi-annually data reported by the company within the most recent 12 months, which was $425.8 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Revenue →
What does a Revenue of $425.8 Mil mean?
Ryman Healthcare (RYHTY) has a Revenue of $425.8 Mil as of Mar. 2025. Revenue is the total amount a company generates as sales through its operations. View historical data on Ryman Healthcare and its competitors.
Is Ryman Healthcare's Revenue too high?
Ryman Healthcare's current Revenue is $425.8 Mil. Overall, Ryman Healthcare has a GF Score™ of 70/100, reflecting its overall financial health beyond just this single metric.
How does Ryman Healthcare's Revenue compare to HCA and THC?
Ryman Healthcare's Revenue of $425.8 Mil can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Revenue for a Healthcare Providers & Services company?
A good Revenue depends on the Healthcare Providers & Services industry context. However, Revenue should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Revenue mean?
A high Revenue can signal that a stock is expensive relative to its fundamentals. Revenue is the total amount a company generates as sales through its operations. View historical data on Ryman Healthcare and its competitors. Ryman Healthcare's current Revenue is $425.8 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Ryman Healthcare stock overvalued right now?
Ryman Healthcare (RYHTY) has a current Revenue of $425.8 Mil. The current Revenue is $425.8 Mil. Ryman Healthcare's overall GF Score™ is 70/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Revenue calculated?
Revenue is calculated from a company's financial statements. For Ryman Healthcare (RYHTY), the current Revenue is $425.8 Mil as of Mar. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Ryman Healthcare Business Description

Address 92 Russley Road, P.O. Box 771, Christchurch, CT, NZL, 8042
Ryman Healthcare Ltd is a retirement living and aged care provider operating in New Zealand and Australia. It owns and operates integrated retirement villages through its trading subsidiaries, which operate in the aged care and retirement living sector in New Zealand and Australia. The Group operates in a single industry: the provision of integrated retirement living and aged care for older people in New Zealand and Australia. The majority of revenue is derived from Care and village fees, which relate to the provision of accommodation, care and related services to aged care residents and retirement living residents.
70GF Score

Get the complete analysis for RYHTY

Revenue is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$6.11
Price